Advertisement
Advertisement
PLSE
Pulse Biosciences, Inc Common Stock (DE)
22.02
USDSponsored
+0.68
+3.17%
Mar 25, 15:56 UTC -4
Closed
Pre-Market
21.69
-0.33
-1.50%
PLSE Earnings Reports
Positive Surprise Ratio
PLSE beat 10 of 23 last estimates.
43%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$408.00K
/-$0.32
Implied change from Q4 25 (Revenue/ EPS)
+54.55%
/+23.08%
Implied change from Q1 25 (Revenue/ EPS)
--
/+88.24%
Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue
On Feb 19, 2026, PLSE reported earnings of -0.26 USD per share (EPS) for Q4 25, beating the estimate of -0.31 USD, resulting in a 17.77% surprise. Revenue reached 264.00 thousand, compared to an expected 255.00 thousand, with a 3.53% difference. The market reacted with a -14.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 408.00 thousand USD, implying an increase of 23.08% EPS, and increase of 54.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.26
Surprise
-27.45%
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.21
Surprise
-65.56%
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.73%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
DarioHealth Corp. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$3.30
Actual
-$3.43
Surprise
-3.71%
Spectral AI, Inc. Class A Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.86%
SiNtx Technologies, Inc. Common Stock
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.56
Actual
-$0.56
Surprise
-1.60%
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.38
Surprise
-3.49%
FAQ
What were Pulse Biosciences, Inc Common Stock (DE)'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.26, beating estimates by 17.77%, and revenue of $264.00K, 3.53% above expectations.
How did the market react to Pulse Biosciences, Inc Common Stock (DE)'s Q4 2025 earnings?
The stock price moved down -14.59%, changed from $25.08 before the earnings release to $21.42 the day after.
When is Pulse Biosciences, Inc Common Stock (DE) expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Pulse Biosciences, Inc Common Stock (DE)'s next earnings report?
Based on 3
analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.32 and revenue of $408.00K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement